AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metglip DS 5mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Ortin Laboratories Ltd

Salt Composition

Glipizide (5mg) + Metformin (500mg)

Overview Metglip DS 5mg/500mg Tablet

Glimepiride/Metformin 5mg/500mg tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar; abrupt cessation without medical consultation can elevate blood glucose, risking complications such as renal impairment, vision loss, neuropathy, and limb amputation. This medication is part of a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle adjustments are vital for effective diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, vertigo, cephalgia, and tremors. Knowing these signs and how to counteract them (e.g., readily available glucose source) is crucial. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, edema, visual disturbances, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal dysfunction. Individuals with a history of cardiovascular disease should consult their physician prior to use. Pregnant or lactating women should seek medical advice before commencing treatment. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Metglip DS 5mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Metglip DS 5mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metglip DS 5mg/500mg Tablet should be administered with a meal.

Common Side effects of Metglip DS 5mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Diarrhea
  • Headache
  • Upper respiratory tract infection

How to use Metglip DS 5mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metglip DS 5mg/500mg Tablet should be administered with a meal.

How Metglip DS 5mg/500mg Tablet works:

Glipizide and Metformin are combined in Metglip DS 5mg/500mg tablets to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Metglip DS 5mg/500mg tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Metglip DS 5mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Metglip DS 5mg/500mg tablets while breastfeeding is likely inadvisable. Available data from humans indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Metglip DS 5mg/500mg Tablets cautiously, potentially requiring dosage modification. Consultation with a physician is necessary. Metglip DS 5mg/500mg Tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Metglip DS 5mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. A low initial dose is typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Metglip DS 5mg/500mg Tablet :

Should you forget a Metglip DS 5mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Metglip DS 5mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Metglip DS 5mg/500mg Tablet

Metglip DS 5mg/500mg tablets combine glipizide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glipizide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Metglip DS 5mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Metglip DS 5mg/500mg can cause low blood sugar (hypoglycemia), with symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other diabetes medication is used concurrently. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, like glucose tablets, honey, or fruit juice.
Metglip DS 5mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA – Metformin-associated lactic acidosis). This rare side effect necessitates avoiding Metglip DS in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Metglip DS and seek immediate medical attention.
Prolonged use of Metglip DS 5mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Metglip DS 5mg/500mg Tablets are contraindicated in patients with allergies to its components or excipients, those with moderate to severe kidney disease, and those with metabolic acidosis, including diabetic ketoacidosis.
Combining Metglip DS 5mg/500mg tablets with alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Metglip DS 5mg/500mg Tabl...
12
MRP 14
16% off